Key Metrics
Price Performance
30-DAY PRICE CHART
1-YEAR PERFORMANCE
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Quest Diagnostics is currently trading at $191.51, which is 10.3% below its 52-week high. With a beta of 0.65, the stock shows lower sensitivity to market movements.
Frequently Asked Questions
Is DGX a good buy right now?
Quest Diagnostics trades at 21.9x earnings. This is near market average. Current risk level is Medium based on 16.4% volatility.
Does DGX pay dividends?
Yes, Quest Diagnostics offers a dividend yield of 1.80%. This translates to approximately $3.45 per share annually.
How volatile is DGX?
With 30-day annualized volatility of 16.4% and beta of 0.65,DGX is classified as Medium risk. The stock tends to be more stable than the market average.
Related Assets
Track DGX Live
Add Quest Diagnostics to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALIMPORT BROKER FILE